Save lives. Post this to your medical friends.
November 26, 2011
Crash-2 going viral
The CRASH-2 trial of tranexamic acid versus placebo in adult trauma patients with significant bleeding reported in 2010. When given within 8 hours, preferably earlier, tranexamic acid reduced all-cause mortality by about a tenth and death due to bleeding by about a sixth, with no increased risk of thromboembolic side-effects.
And it’s as cheap as chips. The cost per life year saved is about $50.
Despite these compelling findings, an audit of UK hospitals in 2011 showed that, of 412 trauma patients who were ill enough to need a blood transfusion and therefore eligible for tranexamic acid treatment, only 12 (3%) received the drug. The implementation rate in low-income and middle-income countries could well be lower still.
Watch the video and post the link to your colleagues. Click here
Jim Thornton
Great ideas!